ABVC BioPharma, Inc. (ABVC) — 分析師展望 / 分析師共識目標價為. 基於 1 位分析師評級, 共識為 中性 — 1 持有.
分析師預估 每股收益(EPS)為 $-4.40 和 營收為 $0.02B (下一財年).
每股收益(EPS)歷史表現: 2024: 實際 $-0.43 vs 預期 $-4.40 (超預期 +90.2%). 2025: 實際 $-0.39 vs 預期 $-4.60 (超預期 +91.5%). 分析師準確度: 0%.
ABVC 分析師評級
Hold
基於過去3個月內 1 位分析師對 ABVC BioPharma, Inc. 的評級
EPS 預測 — ABVC
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.43
vs Est –$4.40
▲ 923.3% off
2025
Actual –$0.39
vs Est –$4.60
▲ 1,079.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
營收預測 — ABVC
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.001B
vs Est $0.015B
▼ 2,748.2% off
2025
Actual $0.001B
vs Est $0.004B
▼ 424.3% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
